96 related articles for article (PubMed ID: 26933216)
1. Revealing the TCR bias for MHC molecules.
Krovi SH; Gapin L
Proc Natl Acad Sci U S A; 2016 Mar; 113(11):2809-11. PubMed ID: 26933216
[No Abstract] [Full Text] [Related]
2. Functional evidence for TCR-intrinsic specificity for MHCII.
Parrish HL; Deshpande NR; Vasic J; Kuhns MS
Proc Natl Acad Sci U S A; 2016 Mar; 113(11):3000-5. PubMed ID: 26831112
[TBL] [Abstract][Full Text] [Related]
3. Evolutionarily conserved features contribute to αβ T cell receptor specificity.
Scott-Browne JP; Crawford F; Young MH; Kappler JW; Marrack P; Gapin L
Immunity; 2011 Oct; 35(4):526-35. PubMed ID: 21962492
[TBL] [Abstract][Full Text] [Related]
4. How the T cell repertoire becomes peptide and MHC specific.
Huseby ES; White J; Crawford F; Vass T; Becker D; Pinilla C; Marrack P; Kappler JW
Cell; 2005 Jul; 122(2):247-60. PubMed ID: 16051149
[TBL] [Abstract][Full Text] [Related]
5. T-splenocytes from non-obese diabetic mice binding to xenogeneic pancreatic beta-cells in vitro. Implication of the alpha/beta T-cell receptor and of major histocompatibility complex class II molecules from target cells.
Martignat L; Feve B; Ouary M; Pogu S; Charbonnel B; Saï P
J Autoimmun; 1993 Dec; 6(6):753-69. PubMed ID: 8155255
[TBL] [Abstract][Full Text] [Related]
6. The orientation of a T cell receptor to its MHC class II:peptide ligands.
Hong SC; Sant'Angelo DB; Dittel BN; Medzhitov R; Yoon ST; Waterbury PG; Janeway CA
J Immunol; 1997 Nov; 159(9):4395-402. PubMed ID: 9379037
[TBL] [Abstract][Full Text] [Related]
7. Superantigen-like properties of an antibody bispecific for MHC class II molecules and the V beta domain of the T cell antigen receptor.
Yagi J; Nakata M; Uchiyama T; Nishikawa M; Mizushima Y; Nishioka K; Ito K; Yagita H; Okumura K; Janeway CA
J Immunol; 1994 Apr; 152(8):3833-41. PubMed ID: 8144952
[TBL] [Abstract][Full Text] [Related]
8. Class II major histocompatibility complex mutant mice to study the germ-line bias of T-cell antigen receptors.
Silberman D; Krovi SH; Tuttle KD; Crooks J; Reisdorph R; White J; Gross J; Matsuda JL; Gapin L; Marrack P; Kappler JW
Proc Natl Acad Sci U S A; 2016 Sep; 113(38):E5608-17. PubMed ID: 27588903
[TBL] [Abstract][Full Text] [Related]
9. The T cell antigen receptor: the Swiss army knife of the immune system.
Attaf M; Legut M; Cole DK; Sewell AK
Clin Exp Immunol; 2015 Jul; 181(1):1-18. PubMed ID: 25753381
[TBL] [Abstract][Full Text] [Related]
10. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
[TBL] [Abstract][Full Text] [Related]
11. Antigen-selected T-cell receptor diversity and self-nonself homology.
Casanova JL; Maryanski JL
Immunol Today; 1993 Aug; 14(8):391-4. PubMed ID: 8397778
[TBL] [Abstract][Full Text] [Related]
12. Dual MHC class I and class II restriction of a single T cell receptor: distinct modes of tolerance induction by two classes of autoantigens.
Arsov I; Vukmanović S
J Immunol; 1999 Feb; 162(4):2008-15. PubMed ID: 9973472
[TBL] [Abstract][Full Text] [Related]
13. Unique T cell antagonist properties of the exact self-correlate of a peptide antigen revealed by self-substitution of non-self-positions in the peptide sequence.
Schountz T; Kasselman JP; Ford SR; Murray JS
Cell Immunol; 1996 Mar; 168(2):193-200. PubMed ID: 8640865
[TBL] [Abstract][Full Text] [Related]
14. Unexpected T-cell diversity in syngeneic graft-versus-host disease revealed by interaction with peptide-loaded soluble MHC class II molecules.
Hess AD; Thoburn CJ; Chen W; Bright AE
Transplantation; 2003 Apr; 75(8):1361-7. PubMed ID: 12717231
[TBL] [Abstract][Full Text] [Related]
15. A novel HLA class II-independent TCR-mediated T cell activation mechanism is distinguished by the V beta specificity of the proliferating oligoclones and their capacity to generate interleukin-2.
Dennig D; Yan Y; Ferguson K; O'Reilly RJ
Cell Immunol; 1996 Aug; 171(2):200-10. PubMed ID: 8806788
[TBL] [Abstract][Full Text] [Related]
16. MHC control of the naive TCR alpha-chain repertoire.
Merkenschlager M; Benoist C; Mathis D
J Immunol; 1994 Oct; 153(7):3005-13. PubMed ID: 8089483
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of thymocyte positive selection by natural MHC: peptide ligands.
Tourne S; Kouskoff V; Ho W; Davis M; Benoist C; Mathis D
Eur J Immunol; 1999 Feb; 29(2):394-402. PubMed ID: 10064054
[TBL] [Abstract][Full Text] [Related]
18. Major histocompatibility class I molecules present Urtica dioica agglutinin, a superantigen of vegetal origin, to T lymphocytes.
Rovira P; Buckle M; Abastado JP; Peumans WJ; Truffa-Bachi P
Eur J Immunol; 1999 May; 29(5):1571-80. PubMed ID: 10359111
[TBL] [Abstract][Full Text] [Related]
19. Use of bispecific heteroconjugated antibodies (anti-T cell antigen receptor x anti-MHC class II) to study activation of T cells with a full length or truncated antigen receptor zeta-chain.
Wu S; Yang Y; Sadegh-Nasseri S; Ashwell JD
J Immunol; 1993 Mar; 150(6):2211-21. PubMed ID: 8450208
[TBL] [Abstract][Full Text] [Related]
20. Negative selection of thymocytes expressing the D10 TCR.
Sant'Angelo DB; Janeway CA
Proc Natl Acad Sci U S A; 2002 May; 99(10):6931-6. PubMed ID: 12011450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
